Treatment method with SR18662 considerably lowers expansion and proliferation of CRC cells. SR18662 demonstrates improved efficacy in cutting down viability of numerous CRC cell lines. Circulation cytometry Investigation next SR18662 therapy shows an increase in cells captured in either S or G2/M phases of the cell cycle and a substantial https://johnnyk208ycf0.wikimidpoint.com/user